Ubs Group Ag Exact Sciences Corp Call Options Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $1.47 Million - $1.93 Million	26,100 New	26,100 $1.8 Million
Q2 2022 Aug 10, 2022	SELL	$35.61 - $76.23 $797,664 - $1.71 Million	-22,400 Reduced 31.11%	49,600 $1.95 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $3.91 Million - $5.61 Million	68,000 Added 1700.0%	72,000 $5.03 Million
Q1 2020 May 01, 2020	BUY	$37.9 - $104.44 $151,600 - $417,760	4,000 New	4,000 $232,000

699

160M

5.84M

2.58M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.64B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.